Both in Pharmaceuticals
Damora Therapeutics vs Kardigan
Over the past year DMRA returned −26.4% and KARD returned −27.1%; their daily moves had a correlation of 0.65.
DMRA −26.4% KARD −27.1%Growth of $1, one year, split-adjusted
| Metric | DMRA | KARD |
|---|---|---|
| Price | $20.67 | $13.51 |
| Market cap | $1.28B | $1.26B |
| Today | +7.27% | +4.40% |
| 1 month | −9.5% | −17.1% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $540.5M | $597.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 10.3% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).